US Bancorp DE Has $21.15 Million Stock Holdings in Xylem Inc. $XYL

US Bancorp DE reduced its position in Xylem Inc. (NYSE:XYLFree Report) by 4.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 143,390 shares of the industrial products company’s stock after selling 6,393 shares during the period. US Bancorp DE’s holdings in Xylem were worth $21,150,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. SJS Investment Consulting Inc. lifted its position in shares of Xylem by 1,844.4% in the third quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company’s stock valued at $26,000 after buying an additional 166 shares during the last quarter. First Horizon Corp bought a new stake in Xylem in the 3rd quarter valued at $30,000. Grey Fox Wealth Advisors LLC acquired a new stake in Xylem during the 3rd quarter valued at $34,000. Caldwell Trust Co acquired a new position in shares of Xylem in the second quarter valued at $41,000. Finally, FWL Investment Management LLC bought a new position in shares of Xylem in the second quarter valued at about $43,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Trading Down 1.9%

Shares of XYL stock opened at $129.46 on Friday. The stock has a market cap of $31.48 billion, a P/E ratio of 33.02, a price-to-earnings-growth ratio of 1.89 and a beta of 1.17. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $154.27. The company has a current ratio of 1.62, a quick ratio of 1.28 and a debt-to-equity ratio of 0.12. The stock has a 50 day simple moving average of $136.69 and a 200 day simple moving average of $141.14.

Xylem (NYSE:XYLGet Free Report) last announced its quarterly earnings data on Tuesday, February 10th. The industrial products company reported $1.42 earnings per share for the quarter, meeting the consensus estimate of $1.42. Xylem had a return on equity of 11.11% and a net margin of 10.59%.Xylem’s revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.18 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. On average, research analysts predict that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem declared that its Board of Directors has approved a stock repurchase plan on Wednesday, February 25th that permits the company to repurchase $1.50 billion in shares. This repurchase authorization permits the industrial products company to purchase up to 4.8% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its shares are undervalued.

Xylem Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 24th. Investors of record on Tuesday, February 24th will be given a dividend of $0.43 per share. This is a positive change from Xylem’s previous quarterly dividend of $0.40. This represents a $1.72 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend is Tuesday, February 24th. Xylem’s dividend payout ratio (DPR) is currently 43.88%.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. Stifel Nicolaus reduced their target price on shares of Xylem from $178.00 to $175.00 and set a “buy” rating for the company in a report on Wednesday, February 11th. UBS Group restated a “buy” rating and set a $155.00 price objective on shares of Xylem in a research report on Friday, February 13th. Oppenheimer set a $165.00 price objective on Xylem in a report on Thursday, February 12th. Barclays lowered their target price on Xylem from $166.00 to $156.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 11th. Finally, Mizuho set a $138.00 price target on Xylem in a report on Wednesday, February 11th. Nine equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, Xylem presently has a consensus rating of “Moderate Buy” and an average target price of $158.08.

View Our Latest Stock Report on XYL

Xylem Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

See Also

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.